Effect of tachykinin receptor antagonists in experimental neuropathic pain

By Coudore-Civiale M.-A.   Courteix C.   Eschalier A.   Fialip J.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 175-184

Elsevier

Access to resources Recommend Favorite

NK 1 (substance P) receptor antagonists - why are they not analgesic in humans?

By Hill R.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 244-246

Elsevier

Access to resources Recommend Favorite

Tachykinin NK1 receptor antagonists for the control of chemotherapy-induced nausea and vomiting

By Gale Jeremy D   O’Neill Brian T   Humphrey John M  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 12, 2001-12 ,pp. : 1837-1847

Informa Healthcare

Access to resources Recommend Favorite

A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 17, Iss. 6, 2010-02 ,pp. : 504-516

Bentham Science Publishers

Access to resources Recommend Favorite

NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 12, 2011-04 ,pp. : 1820-1831

Bentham Science Publishers

Access to resources Recommend Favorite